{"id":"https://openalex.org/W2965347002","doi":"https://doi.org/10.1089/hgtb.2019.088","title":"Analytical Strategies for Quantification of Adeno-Associated Virus Empty Capsids to Support Process Development","display_name":"Analytical Strategies for Quantification of Adeno-Associated Virus Empty Capsids to Support Process Development","publication_year":2019,"publication_date":"2019-08-01","ids":{"openalex":"https://openalex.org/W2965347002","doi":"https://doi.org/10.1089/hgtb.2019.088","mag":"2965347002","pmid":"https://pubmed.ncbi.nlm.nih.gov/31368356"},"language":"en","primary_location":{"id":"doi:10.1089/hgtb.2019.088","doi":"https://doi.org/10.1089/hgtb.2019.088","is_oa":false,"landing_page_url":"https://doi.org/10.1089/hgtb.2019.088","pdf_url":null,"source":{"id":"https://openalex.org/S2495496942","display_name":"Human Gene Therapy Methods","issn_l":"1946-6536","issn":["1946-6536","1946-6544"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","poland-70"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Gene Therapy Methods","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026804722","display_name":"Xiaotong Fu","orcid":"https://orcid.org/0009-0006-3817-9175","observed_orcids":["https://orcid.org/0009-0006-3817-9175","https://orcid.org/0009-0003-8214-9123"]},"institutions":[{"id":"https://openalex.org/I1297540436","display_name":"Biogen (United States)","ror":"https://ror.org/02jqkb192","country_code":"US","type":"company","lineage":["https://openalex.org/I1297540436"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Xiaotong Fu","raw_affiliation_strings":["Gene Therapy, Process Development and Biogen, Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gene Therapy, Process Development and Biogen, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I1297540436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080254267","display_name":"Wei\u2010Chiang Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1297540436","display_name":"Biogen (United States)","ror":"https://ror.org/02jqkb192","country_code":"US","type":"company","lineage":["https://openalex.org/I1297540436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wei-Chiang Chen","raw_affiliation_strings":["Analytical Development, Biogen, Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Analytical Development, Biogen, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I1297540436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072811013","display_name":"Christopher Argento","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1297540436","display_name":"Biogen (United States)","ror":"https://ror.org/02jqkb192","country_code":"US","type":"company","lineage":["https://openalex.org/I1297540436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher Argento","raw_affiliation_strings":["Gene Therapy, Process Development and Biogen, Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gene Therapy, Process Development and Biogen, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I1297540436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001668630","display_name":"Peter Clarner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1297540436","display_name":"Biogen (United States)","ror":"https://ror.org/02jqkb192","country_code":"US","type":"company","lineage":["https://openalex.org/I1297540436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter Clarner","raw_affiliation_strings":["Analytical Development, Biogen, Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Analytical Development, Biogen, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I1297540436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009828814","display_name":"Vinay Bhatt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1297540436","display_name":"Biogen (United States)","ror":"https://ror.org/02jqkb192","country_code":"US","type":"company","lineage":["https://openalex.org/I1297540436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vinay Bhatt","raw_affiliation_strings":["Analytical Development, Biogen, Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Analytical Development, Biogen, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I1297540436"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Ryan Dickerson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1297540436","display_name":"Biogen (United States)","ror":"https://ror.org/02jqkb192","country_code":"US","type":"company","lineage":["https://openalex.org/I1297540436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ryan Dickerson","raw_affiliation_strings":["Gene Therapy, Process Development and Biogen, Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gene Therapy, Process Development and Biogen, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I1297540436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020260035","display_name":"George M. Bou-Assaf","orcid":"https://orcid.org/0000-0003-4285-5915","observed_orcids":["https://orcid.org/0000-0003-4285-5915"]},"institutions":[{"id":"https://openalex.org/I1297540436","display_name":"Biogen (United States)","ror":"https://ror.org/02jqkb192","country_code":"US","type":"company","lineage":["https://openalex.org/I1297540436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"George Bou-Assaf","raw_affiliation_strings":["Analytical Development, Biogen, Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Analytical Development, Biogen, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I1297540436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079060705","display_name":"Meisam Bakhshayeshi","orcid":"https://orcid.org/0000-0002-0376-9187","observed_orcids":["https://orcid.org/0000-0002-0376-9187"]},"institutions":[{"id":"https://openalex.org/I1297540436","display_name":"Biogen (United States)","ror":"https://ror.org/02jqkb192","country_code":"US","type":"company","lineage":["https://openalex.org/I1297540436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Meisam Bakhshayeshi","raw_affiliation_strings":["Gene Therapy, Process Development and Biogen, Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gene Therapy, Process Development and Biogen, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I1297540436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5125316008","display_name":"Xiaohui Lu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1297540436","display_name":"Biogen (United States)","ror":"https://ror.org/02jqkb192","country_code":"US","type":"company","lineage":["https://openalex.org/I1297540436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiaohui Lu","raw_affiliation_strings":["Analytical Development, Biogen, Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Analytical Development, Biogen, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I1297540436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021236664","display_name":"Svetlana Bergelson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1297540436","display_name":"Biogen (United States)","ror":"https://ror.org/02jqkb192","country_code":"US","type":"company","lineage":["https://openalex.org/I1297540436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Svetlana Bergelson","raw_affiliation_strings":["Analytical Development, Biogen, Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Analytical Development, Biogen, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I1297540436"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5062150311","display_name":"John P. Pieracci","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1297540436","display_name":"Biogen (United States)","ror":"https://ror.org/02jqkb192","country_code":"US","type":"company","lineage":["https://openalex.org/I1297540436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Pieracci","raw_affiliation_strings":["Gene Therapy, Process Development and Biogen, Cambridge, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gene Therapy, Process Development and Biogen, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I1297540436"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5026804722"],"corresponding_institution_ids":["https://openalex.org/I1297540436"],"apc_list":null,"apc_paid":null,"fwci":3.8605,"has_fulltext":false,"cited_by_count":82,"citation_normalized_percentile":{"value":0.94468222,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"30","issue":"4","first_page":"144","last_page":"152"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":0.005900000222027302,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11663","display_name":"Viral Infectious Diseases and Gene Expression in Insects","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/recombinant-adeno-associated-virus","display_name":"recombinant adeno-associated virus","score":0.9160000085830688},{"id":"https://openalex.org/keywords/empty-capsids","display_name":"empty capsids","score":0.9010000228881836},{"id":"https://openalex.org/keywords/viral-vector-purification","display_name":"viral vector purification","score":0.8080000281333923},{"id":"https://openalex.org/keywords/gene-therapy-vectors","display_name":"gene therapy vectors","score":0.6119999885559082},{"id":"https://openalex.org/keywords/method-comparability","display_name":"method comparability","score":0.6520000100135803},{"id":"https://openalex.org/keywords/transmission-electron-microscopy","display_name":"transmission electron microscopy","score":0.7889999747276306},{"id":"https://openalex.org/keywords/analytical-ultracentrifugation","display_name":"analytical ultracentrifugation","score":0.9869999885559082},{"id":"https://openalex.org/keywords/process-development","display_name":"process development","score":0.6060000061988831}],"concepts":[{"id":"https://openalex.org/C202878990","wikidata":"https://www.wikidata.org/wiki/Q830465","display_name":"Capsid","level":3,"score":0.938420295715332},{"id":"https://openalex.org/C2778107364","wikidata":"https://www.wikidata.org/wiki/Q355989","display_name":"Adeno-associated virus","level":5,"score":0.8736811876296997},{"id":"https://openalex.org/C2910425616","wikidata":"https://www.wikidata.org/wiki/Q85741465","display_name":"Analytical Ultracentrifugation","level":3,"score":0.5834117531776428},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5780127644538879},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.5649115443229675},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.5051701664924622},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.4484269917011261},{"id":"https://openalex.org/C111599444","wikidata":"https://www.wikidata.org/wiki/Q213901","display_name":"Genetic enhancement","level":3,"score":0.4459383189678192},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.3879835605621338},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.34611383080482483},{"id":"https://openalex.org/C54689828","wikidata":"https://www.wikidata.org/wiki/Q2029259","display_name":"Ultracentrifuge","level":2,"score":0.30473148822784424},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.20139369368553162},{"id":"https://openalex.org/C92087593","wikidata":"https://www.wikidata.org/wiki/Q427389","display_name":"Vector (molecular biology)","level":4,"score":0.10463935136795044},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0897572934627533}],"mesh":[{"descriptor_ui":"D000229","descriptor_name":"Dependovirus","qualifier_ui":"Q000648","qualifier_name":"ultrastructure","is_major_topic":true},{"descriptor_ui":"D002213","descriptor_name":"Capsid","qualifier_ui":"Q000648","qualifier_name":"ultrastructure","is_major_topic":true},{"descriptor_ui":"D002851","descriptor_name":"Chromatography, High Pressure Liquid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015316","descriptor_name":"Genetic Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D046529","descriptor_name":"Microscopy, Electron, Transmission","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1089/hgtb.2019.088","doi":"https://doi.org/10.1089/hgtb.2019.088","is_oa":false,"landing_page_url":"https://doi.org/10.1089/hgtb.2019.088","pdf_url":null,"source":{"id":"https://openalex.org/S2495496942","display_name":"Human Gene Therapy Methods","issn_l":"1946-6536","issn":["1946-6536","1946-6544"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","poland-70"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Gene Therapy Methods","raw_type":"journal-article"},{"id":"pmid:31368356","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31368356","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human gene therapy methods","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.4000000059604645}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W123445147","https://openalex.org/W1795014780","https://openalex.org/W1970939924","https://openalex.org/W1973658117","https://openalex.org/W1975317507","https://openalex.org/W1978564724","https://openalex.org/W1979659851","https://openalex.org/W2001599454","https://openalex.org/W2009310029","https://openalex.org/W2027879493","https://openalex.org/W2032583774","https://openalex.org/W2048842430","https://openalex.org/W2052642203","https://openalex.org/W2058942457","https://openalex.org/W2079090019","https://openalex.org/W2088763985","https://openalex.org/W2101428586","https://openalex.org/W2120058480","https://openalex.org/W2150815545","https://openalex.org/W2172230191","https://openalex.org/W2439361170","https://openalex.org/W2746053108","https://openalex.org/W2746153430","https://openalex.org/W4245087155"],"related_works":["https://openalex.org/W3154377315","https://openalex.org/W4388153358","https://openalex.org/W4385239696","https://openalex.org/W4399708576","https://openalex.org/W3200117221","https://openalex.org/W4306385424","https://openalex.org/W4390786903","https://openalex.org/W4309673733","https://openalex.org/W4413115300","https://openalex.org/W3156335430"],"abstract_inverted_index":{"Recombinant":[0],"adeno-associated":[1],"virus":[2],"(rAAV)-mediated":[3],"gene":[4,26],"therapy":[5,27],"is":[6,28,97],"a":[7,21,112],"fast-evolving":[8],"field":[9],"in":[10,19,67,76,146],"the":[11,16,43,51,60,68,82,89,121,137,159],"biotechnology":[12],"industry.":[13],"One":[14],"of":[15,85,93,125],"major":[17],"challenges":[18],"developing":[20],"purification":[22],"process":[23,105],"for":[24],"AAV":[25],"establishing":[29],"an":[30],"effective":[31],"yet":[32],"scalable":[33],"method":[34,131],"to":[35,99,103,119,164],"remove":[36],"empty":[37,86],"capsids,":[38,87],"or":[39],"viral":[40,77,166],"vectors":[41],"lacking":[42],"therapeutic":[44,52],"gene,":[45],"from":[46],"full":[47],"capsids-viral":[48],"product":[49],"containing":[50],"sequence.":[53],"Several":[54],"analytical":[55,95,142],"methods":[56,96,144],"that":[57],"can":[58,73],"quantify":[59],"empty-to-full":[61,122,147],"capsid":[62,123,148],"ratio":[63,124,149],"have":[64],"been":[65],"reported":[66],"literature.":[69],"However,":[70],"as":[71],"samples":[72],"vary":[74],"widely":[75],"titer,":[78],"buffer":[79],"matrix,":[80],"and":[81,91,141,157],"relative":[83],"level":[84],"understanding":[88],"specifications":[90],"limitations":[92],"different":[94],"critical":[98],"providing":[100,152],"appropriate":[101],"support":[102],"facilitate":[104],"development.":[106],"In":[107],"this":[108],"study,":[109],"we":[110],"developed":[111,130],"novel":[113],"anion-exchange":[114],"high-performance":[115],"liquid":[116],"chromatography":[117],"assay":[118,155],"determine":[120],"rAAV":[126],"samples.":[127],"The":[128],"newly":[129],"demonstrated":[132],"good":[133],"comparability":[134],"with":[135],"both":[136],"transmission":[138],"electron":[139],"microscopy":[140],"ultracentrifugation":[143],"used":[145],"quantification,":[150],"while":[151],"much":[153],"higher":[154],"throughput":[156],"reducing":[158],"minimum":[160],"sample":[161],"concentration":[162],"requirement":[163],"2.7E11":[165],"genomes/mL.":[167]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":15},{"year":2024,"cited_by_count":15},{"year":2023,"cited_by_count":19},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":20},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2019-08-13T00:00:00"}